Recently, for endometrial cancer similar observations have been described confirming promoter-binding sites for the Wnt/β-catenin inducing transcription factor LEF-1 and, interestingly, also for the EMT inducing transcription factors SNAI1 and SNAI2 [60]. This evidence concerns the gene SNAI2 and endometrial cancer.